JD HEALTH
06618
BIDU-SW
09888
NTES-S
09999
JD-SW
09618
ALI HEALTH
00241
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -802.91%-2.86B | ---- | -396.41%-316.2M | ---- | -81.68%106.68M | ---- | 80.22%582.37M | ---- | 39.89%323.15M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 42.42%-1.06M | ---- | 15.67%-1.85M | ---- | 44.93%-2.19M | ---- | -64.46%-3.98M | ---- | 64.15%-2.42M |
Attributable subsidiary (profit) loss | ---- | 259.16%705.9M | ---- | 2,190.88%196.54M | ---- | 96.43%-9.4M | ---- | -294.14%-263.57M | ---- | -961.81%-66.87M |
Impairment and provisions: | ---- | 1,422.37%1.24B | ---- | 143.11%81.51M | ---- | 111.68%33.53M | ---- | 313.44%15.84M | ---- | 137.10%3.83M |
-Impairment of property, plant and equipment (reversal) | ---- | 35.77%13.31M | ---- | --9.81M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | 500.48%15.72M | ---- | -236.33%-3.93M | ---- | -73.68%2.88M | ---- | 273.86%10.94M | ---- | 132.42%2.93M |
-Impairment of trade receivables (reversal) | ---- | 1,447.06%1.17B | ---- | 146.65%75.52M | ---- | 529.09%30.62M | ---- | 203.81%4.87M | ---- | 222.95%1.6M |
-Other impairments and provisions | ---- | 39,112.61%43.53M | ---- | 258.06%111K | ---- | -6.06%31K | ---- | 104.73%33K | ---- | -34,950.00%-697K |
Revaluation surplus: | ---- | 192.00%5.11M | ---- | 165.81%1.75M | ---- | -55.81%658K | ---- | 887.83%1.49M | ---- | 81.10%-189K |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 125.00%900K | ---- | 140.00%400K |
-Derivative financial instruments fair value (increase) | ---- | 192.00%5.11M | ---- | 165.81%1.75M | ---- | 11.71%658K | ---- | 200.00%589K | ---- | ---589K |
Asset sale loss (gain): | ---- | 122.35%6.08M | ---- | 155.80%2.73M | ---- | 46.75%-4.9M | ---- | -1,936.73%-9.2M | ---- | 38.78%501K |
-Loss (gain) from sale of subsidiary company | ---- | --7.17M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -139.76%-1.09M | ---- | 228.96%2.73M | ---- | -147.91%-2.12M | ---- | 783.23%4.43M | ---- | 38.78%501K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | 79.60%-2.78M | ---- | ---13.63M | ---- | ---- |
Depreciation and amortization: | ---- | -5.86%257.25M | ---- | -17.03%273.26M | ---- | 0.12%329.35M | ---- | 17.14%328.95M | ---- | 40.95%280.8M |
-Amortization of intangible assets | ---- | ---- | ---- | -50.00%1.44M | ---- | -0.03%2.88M | ---- | 0.00%2.88M | ---- | 6.63%2.88M |
Financial expense | ---- | 35.81%316.18M | ---- | 10.66%232.81M | ---- | -4.60%210.39M | ---- | -11.53%220.54M | ---- | 30.28%249.3M |
Special items | ---- | 2,041.73%58.72M | ---- | -111.37%-3.02M | ---- | 124.14%26.61M | ---- | 1,431.61%11.87M | ---- | 103.55%775K |
Operating profit before the change of operating capital | ---- | -156.88%-265.94M | ---- | -32.31%467.55M | ---- | -21.89%690.72M | ---- | 12.10%884.3M | ---- | 37.01%788.87M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 133.74%123.49M | ---- | 152.12%52.83M | ---- | 74.04%-101.36M | ---- | -376.28%-390.43M | ---- | 145.75%141.32M |
Accounts receivable (increase)decrease | ---- | 134.00%124.43M | ---- | 82.50%-365.96M | ---- | -447.97%-2.09B | ---- | 483.91%600.96M | ---- | 35.28%-156.53M |
Accounts payable increase (decrease) | ---- | 292.84%108.87M | ---- | -104.28%-56.46M | ---- | 2,160.55%1.32B | ---- | -84.08%58.31M | ---- | 201.09%366.13M |
prepayments (increase)decrease | ---- | 17.90%145.23M | ---- | -10.00%123.18M | ---- | 440.42%136.86M | ---- | 72.32%-40.2M | ---- | -177.27%-145.25M |
Special items for working capital changes | ---- | -98.93%1.28M | ---- | 115.69%119.67M | ---- | -202.08%-762.57M | ---- | 1,448.00%747.02M | ---- | --48.26M |
Cash from business operations | ---- | -30.36%237.36M | ---- | 142.10%340.81M | ---- | -143.52%-809.43M | ---- | 78.36%1.86B | ---- | 798.74%1.04B |
Hong Kong profits tax paid | ---- | 37.45%-4.22M | ---- | -13.03%-6.74M | ---- | -145.06%-5.96M | ---- | 1,993.51%13.23M | ---- | 110.67%632K |
Other taxs | ---- | 88.07%-2.51M | ---- | 5.57%-21.07M | ---- | 47.79%-22.31M | ---- | -40.13%-42.73M | ---- | 36.61%-30.49M |
Interest paid - operating | ---- | -5.17%-3.68M | ---- | 11.97%-3.5M | ---- | -51.14%-3.98M | ---- | -152.59%-2.63M | ---- | -8,583.33%-1.04M |
Special items of business | -21.91%98.42M | ---- | 513.95%126.03M | ---- | 102.55%20.53M | ---- | -243.48%-804.87M | ---- | 471.99%560.95M | ---- |
Net cash from operations | -21.91%98.42M | -26.67%226.95M | 513.95%126.03M | 136.77%309.51M | 102.55%20.53M | -146.05%-841.68M | -243.48%-804.87M | 80.63%1.83B | 471.99%560.95M | 597.81%1.01B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -42.42%1.06M | ---- | -15.67%1.85M | ---- | -44.93%2.19M | ---- | 23.56%3.98M | ---- | 2.16%3.22M |
Restricted cash (increase) decrease | ---31K | 99.01%-278K | ---- | -525.36%-28.17M | ---- | -129.94%-4.5M | ---- | 3,630.75%15.04M | ---- | 99.48%-426K |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 268.04%48.82M | ---- | -188.68%-29.05M |
Decrease in deposits (increase) | -98.41%294K | 63.64%21.43M | -24.87%18.54M | 3,696.98%13.09M | 72.97%24.68M | -101.33%-364K | -47.69%14.27M | 284.78%27.37M | -35.62%27.28M | -112.68%-14.81M |
Sale of fixed assets | ---- | ---- | ---- | -91.25%7.84M | -99.54%392K | 957.71%89.69M | -63.74%85.97M | 20,090.48%8.48M | --237.07M | 320.00%42K |
Purchase of fixed assets | 58.69%-22.43M | 42.23%-98.24M | 9.06%-54.28M | 46.17%-170.07M | 72.83%-59.69M | -3.23%-315.92M | -528.02%-219.67M | 54.20%-306.05M | 76.43%-34.98M | 29.07%-668.26M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.37%-152K | ---- | 61.58%-9.31M |
Sale of subsidiaries | ---- | ---52K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | --16.38M | --7.78M | ---- | ---- | ---- | -90.62%26.48M | ---- | --282.31M | ---- | ---- |
Cash on investment | ---- | 18.74%-4.12M | ---- | 77.02%-5.07M | ---- | 96.86%-22.08M | ---- | -2,920.48%-702.41M | ---- | 96.93%-23.26M |
Other items in the investment business | 3,276.06%114.08M | 197.17%43.12M | 94.21%-3.59M | -245.06%-44.38M | -391.35%-62M | -52.41%30.6M | 107.63%21.28M | 13,209.73%64.29M | -800.69%-279M | --483K |
Net cash from investment operations | 375.35%108.3M | 86.97%-29.3M | 59.29%-39.33M | -15.98%-224.9M | 1.56%-96.62M | 65.27%-193.91M | -97.77%-98.15M | 24.69%-558.33M | 67.94%-49.63M | 53.47%-741.37M |
Net cash before financing | 138.43%206.72M | 133.62%197.65M | 213.94%86.7M | 108.17%84.6M | 91.57%-76.09M | -181.58%-1.04B | -276.61%-903.03M | 369.28%1.27B | 1,001.39%511.32M | 115.06%270.52M |
Cash flow from financing activities | ||||||||||
New borrowing | -7.05%814.36M | -31.41%1.91B | -46.51%876.09M | -40.24%2.79B | -31.84%1.64B | 83.18%4.67B | 55.41%2.4B | -41.18%2.55B | -28.56%1.55B | 31.41%4.33B |
Refund | 14.84%-795.75M | 32.43%-2.02B | 40.24%-934.41M | 24.56%-2.99B | 11.04%-1.56B | -10.24%-3.96B | 4.08%-1.76B | 12.38%-3.6B | -7.25%-1.83B | -139.04%-4.1B |
Issuing shares | ---- | --228.03M | ---- | ---- | ---- | ---- | ---- | 70,026.71%296.64M | ---- | -56.30%423K |
Interest paid - financing | ---- | -45.66%-276.68M | ---- | -34.39%-189.96M | ---- | 12.73%-141.35M | ---- | 23.23%-161.97M | ---- | -28.97%-210.98M |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | 83.31%-16.02M | ---- | -265.44%-95.98M | ---- | 68.11%-26.26M |
Issuance expenses and redemption of securities expenses | ---- | 14.62%-11.47M | ---- | 46.50%-13.44M | ---- | -41.68%-25.11M | ---- | -128.58%-17.72M | ---- | -9,841.03%-7.75M |
Other items of the financing business | -204.41%-93.57M | ---- | 66.92%-30.74M | ---4.29M | -59.74%-92.93M | ---- | 35.29%-58.18M | -333.58%-38.06M | 19.77%-89.91M | -122.20%-8.78M |
Net cash from financing operations | 15.84%-74.96M | 57.76%-179.12M | -371.61%-89.06M | -183.45%-424.04M | -103.22%-18.89M | 147.07%508.14M | 255.87%586.7M | -2,949.82%-1.08B | -209.63%-376.41M | -102.66%-35.4M |
Effect of rate | 90.21%-985K | -991.16%-10.79M | -51.69%-10.06M | -44.85%1.21M | -13.10%-6.63M | -89.07%2.2M | -2,827.44%-5.86M | 343.06%20.1M | 104.69%215K | 69.77%-8.27M |
Net Cash | 5,675.92%131.76M | 105.46%18.53M | 97.51%-2.36M | 35.65%-339.44M | 69.97%-94.98M | -377.77%-527.45M | -334.47%-316.32M | -19.24%189.88M | -52.93%134.91M | 150.58%235.12M |
Begining period cash | 6.74%122.44M | -74.67%114.71M | -74.67%114.71M | -53.70%452.93M | -53.70%452.93M | 27.33%978.18M | 14.53%978.18M | 41.90%768.2M | 57.77%854.07M | -47.62%541.35M |
Cash at the end | 147.56%253.22M | 6.74%122.44M | -70.89%102.28M | -74.67%114.71M | -46.44%351.32M | -53.70%452.93M | -33.68%655.99M | 27.33%978.18M | 20.14%989.2M | 41.90%768.2M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.